BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berry T, Abohamza E, Moustafa AA. Treatment-resistant schizophrenia: focus on the transsulfuration pathway. Rev Neurosci 2020;31:219-32. [PMID: 31714892 DOI: 10.1515/revneuro-2019-0057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Zhang J, Yang M, Xu L, Chen W, Sun Y, Zhang X. Catalase and interleukin-6 serum elevation in a prediction of treatment-resistance in male schizophrenia patients. Asian J Psychiatr 2023;79:103400. [PMID: 36521406 DOI: 10.1016/j.ajp.2022.103400] [Reference Citation Analysis]
2 Zhilyaeva TV, Piatoikina AS, Kasyanov ED, Rukavishnikov GV, Semennov IV, Kostina OV, Blagonravova AS, Mazo GE. Biochemical disturbances in schizophrenia — a «window of opportunity». V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY 2022;56:52-62. [DOI: 10.31363/2313-7053-2022-56-4-52-62] [Reference Citation Analysis]
3 Yang X, Yang H, Li N, Li C, Liang W, Zhang X. Increased serum homocysteine in first episode and drug-naïve individuals with schizophrenia: sex differences and correlations with clinical symptoms. BMC Psychiatry 2022;22:759. [PMID: 36463129 DOI: 10.1186/s12888-022-04416-x] [Reference Citation Analysis]
4 Yang X, Yang H, Li N, Li C, Liang W, Zhang X. Increased serum homocysteine in first episode and drug-naïve patients with schizophrenia: Sex differences and correlations with pathophysiology.. [DOI: 10.21203/rs.3.rs-1907810/v1] [Reference Citation Analysis]
5 Gilbert AK, Newton TD, Hettiaratchi MH, Pluth MD. Reactive sulfur and selenium species in the regulation of bone homeostasis. Free Radical Biology and Medicine 2022. [DOI: 10.1016/j.freeradbiomed.2022.08.002] [Reference Citation Analysis]
6 Zhilyaeva TV, Piatoikina AS, Bavrina AP, Kostina OV, Zhukova ES, Shcherbatyuk TG, Blagonravova AS, Dubinina EE, Mazo GE. Homocysteine in Schizophrenia: Independent Pathogenetic Factor with Prooxidant Activity or Integral Marker of Other Biochemical Disturbances? Schizophr Res Treatment 2021;2021:7721760. [PMID: 34707909 DOI: 10.1155/2021/7721760] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ganguly P, Moustafa AA, Hamza EA, Helal AA. Case studies of the treatment of schizophrenia patients. Cognitive and Behavioral Dysfunction in Schizophrenia 2021. [DOI: 10.1016/b978-0-12-820005-6.00005-0] [Reference Citation Analysis]
8 Bryll A, Skrzypek J, Krzyściak W, Szelągowska M, Śmierciak N, Kozicz T, Popiela T. Oxidative-Antioxidant Imbalance and Impaired Glucose Metabolism in Schizophrenia. Biomolecules 2020;10:E384. [PMID: 32121669 DOI: 10.3390/biom10030384] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]